Engaging with Australian patient advocacy groups
We work closely with a wide range of patient organisations in variety of different disease areas such as asthma, infectious diseases and cancer.
We share a vision with these organisations for a healthcare system that provides the best standard of care for preventing, treating and managing disease and ensures people living with an illness have timely access to the most effective treatments, services and information available.
Patient and community disclosure
We provide a range of support for community and patient advocacy organisations across Australia including financial grants, resource in kind and donations. We are committed to working with community organisations with the highest level of transparency and ethical standards.
To ensure common understandings and transparency, a written agreement outlining the conditions and outcomes of our support is developed in consultation with receiving organisations. All patient and community grant and donations are published annually on our website and made available for three years.
Disclosures
2025
GSK donated $55,000 to Inherited Cancers Australia to support various information services and expansion of programmes.
GSK supported Chron's & Colitis Australia by providing $30,000 to support training modules to upskill healthcare professionals.
GSK provided $50,000 to develop and promote a national consensus statement on Hepatitis B priorities.
GSK donated $5000 to support the annual Sports Carnival.
GSK provided $70,000 in funding to Hepatitis Australia, for a proposal to support national hepatitis advocacy,
GSK provided $80,000 to support National Check your Vaccinations Day and filming of patient stories.
GSK donated $65,000 towards several projects spanning immunisation advocacy and COPD disease management.
GSK donated $85,000 to Myeloma Australia, supporting the MCAB Clinical Advisory Board Convening ($15,000), an impact study ($35,000) and a National Awareness Campaign ($35,000).
GSK contributed $25,000 towards the development of material to support and educate people living with heart disease.
GSK donated $97,500 to Asthma Australia, towards Oral Corticosteroid Stewardship Phase 3 and CURE Asthma grant ($45000) (OCS project) and CURE Asthma ($52,500).
GSK donated $100,000 in support of Matter of Vax 2025 and RSV Awareness Week.
GSK supported Rare Cancers Australia with the 2025 CanForum ($30,000), 2025 Policy Reports ($20,000) and Policy Round table series ($30,000).
GSK donated $25,000 to Heart Support Australia to support the updating of existing education resources to include the latest guidance on adult immunisation.
GSK donated $200,000, towards our Doomadgee Partnership ($100,000) and the Mornington Island Partnership ($100,000).
2024
GSK donated $70,000 to Rare Cancers Australia to support a series of projects supporting individuals and families affected by rare cancers.
GSK supported the Paediatric Health Hub, Unyoked Health Foundation by providing $27,000 to support a social media education program.
GSK provided $1,500 to support a webinar on inhalers and the environment.
GSK provided $28,000 to fund a Primary Health Network (PHN) education pilot project.
GSK provided $75,000 in funding to support various education and awareness programs for at risk communities.
GSK provided $60,000 to support immunisation policy and advocacy ($50,000), fundraising at NSM launch ($1,550) and World COPD Day ($10,000).
GSK donated $50,000 to help fund Circle of Support - a peer support and mentoring program.
GSK provided $2,000 to support the conduct of the 2024 DeCastella Run.
GSK provided $25,000 to fund a report on the prevalence and burden of inflammatory bowel disease (IBD) in Australia.
GSK provided $17,000 to support web, email and social media education for those with chronic rhinosinusitis and allergic rhinitis.
GSK provided $65,000 to support with various projects.
GSK provided $15,000 to support the National Patient Organisation Network (NPON) Conference 2025.
GSK provided $25,000 to fund development of materials to support and educate those living with heart disease.
GSK donated $100,000 to support two projects: Matters of Vax 2025, and RSV awareness.
GSK provided $97,500 to support various projects, including digital materials ($52,500) and the Oral Corticosteroid Stewardship Project ($45,000)
GSK provided $85,000 to support multiple of Myeloma Australia's projects.
GSK donated $50,000 for the development and promotion of a national consensus statement on Hepatitis B priorities.
GSK donated $125,000, continuing our Doomadgee Partnership ($75,000) and launching the Mornington Island Partnership ($50,000).
2023
GSK donated $85,000 towards a series of projects on supporting research related to rare cancers.
GSK has provided Ovarian Cancer Australia with a total of $85,833.50 to support research and resource development.
Lung Foundation Australia is the only charity that funds life-saving research, and champion programs and services to support Australians with lung disease and lung cancer hope to live their best life.
GSK donated $5,000 for a matched giving day.
GSK contributed $70,000 to multiple projects designed to raise awareness of IMD in at risk communities, including Aboriginal and Torres Strait Islanders.
GSK contributed $50,000 to the peer support program.
Grant of $35,000 towards the Pain of Shingles research project.
GSK contributed a total of $125,000 to support research, development, and outreach.
GSK contributed $10,000 to print and distribution of hard copy researches to those seeking support.
GSK contributed $40,000 in support of delivering Independent Medical Education: Chronic Kidney Disease detection and management in Primary Care.
GSK provided a grant of $17,000 to support development and delivery of consumer focused educational webinars and web content on allergic diseases, including chronic rhinosinusitis.
GSK contributed $10,000 to research and developing impact report on member patient organisations.
2022
GSK has provided Ovarian Cancer Australia $60,000 in funding to expand their new Exercise & Nutrition program.
GSK donated $25,000 to the Immune Deficiencies Foundation of Australia to fund 'Circle of Support' - a Peer Support and Mentoring Program.
GSK donated $50,000 towards a series of projects supporting individuals and families affected by rare cancers.
Lung Foundation Australia is the only charity that funds life-saving research, and champion programs and services to support Australians with lung disease and lung cancer hope to live their best life.
GSK donated $25,000 to support expansion of their Peer Support Program.
$10,000 sponsorship of the NPON Annual Conference 2023.
Grant for $20,000 to cover the printing costs of Indigenous meningococcal signs and symptoms education materials.
GSK donated $2000 for the conduct of the 2022 DeCastella Run.
Asthma Australia is a for-purpose, consumer organisation with a history of improving the lives of people with asthma. They provide disease education, information, research, community advocacy and support to people with asthma and as well as their careers.
In 2021, GSK donated $159,425 over various Asthma Australia projects. This included funding insights for improved-patient centred care, funding for an OCS Overuse Proposal and funding to support the development of a patient education video series.
GSK donated $75,000 to the Immunisation Foundation of Australia in 2021 to support an adult vaccination community education campaign.
Pink Hope is a preventative health hub that empower people to take charge of their own health. By providing the community with tools to assess, manage and reduce their risk of breast and ovarian cancer. Providing personalised support every step of the way for at-risk women.
GSK provided Pink Hope with $30,000 to support conduct focus groups with sub-sections of their community, to identify gaps in health services and inform their advocacy and campaign efforts.
2021
Asthma Australia is a for-purpose, consumer organisation with a history of improving the lives of people with asthma. They provide disease education, information, research, community advocacy and support to people with asthma and as well as their careers.
In 2021, GSK donated $53,000 over various Asthma Australia projects. This included funding for Aboriginal Webinar Series for Consumers and funding for an educational activity to prompt a different way of thinking about asthma for patients and their support networks including reflection on their symptoms.
Pink Hope is a preventative health hub that empower people to take charge of their own health. By providing the community with tools to assess, manage and reduce their risk of breast and ovarian cancer. Providing personalised support every step of the way for at-risk women.
GSK provided Pink Hope with $72,000 medical grant for disease awareness.
GSK has provided Ovarian Cancer Australia $60,000 for Consumer Survey & Development of a support and resources plan. In aims to support the engagement of a consulting firm to deliver of a survey and develop recommendations which will be outlined in a Support and Resources Plan.
Lung Foundation Australia is the only charity that funds life-saving research, and champion programs and services to support Australians with lung disease and lung cancer hope to live their best life.
GSK donated $52,800 in Supporting consumer access to pulmonary exercise after COVID-19. During the COVID-19 pandemic, LFA suspended operation of its national Lungs in Action (LiA) program to reduce the risk posed by transmission of coronavirus to vulnerable people living with lung conditions. With community transmission declining across Australia, the Lungs in Action program has reopened in October 2020 supported by a comprehensive Roadmap to Recovery Framework.
GSK has donated $40,000 to Centre for Community Driven Research to run structured interview of 50 participants to understand how citizens experience Universal Health Coverage (UHC) in their everyday lives.
Rare Cancers are the peak body for a large range of cancers and CanForum is their annual meeting. Due to logistics required for a virtual meeting GSK has provided $15,000 to assistance with costs towards their November 2021 meeting.
2020
GSK donated $200,000 to the Australian Bushfire crisis.
GSK donated $25,000 to the Australian Bushfire crisis for animal rescue in Victoria.
GSK has donated $25,000 to the Australian Bushfire crisis for animal rescue in NSW.
Funding request for $100,000.00 per year over three years for the Connected Beginnings program in Doomadgee QLD which aims to get children and their parents ready for school and improve their health outcomes.
Sponsorship of the 2nd Annual Conference of the Australia Patient Organisation Network in the amount of $10,000.
Sponsorship for $21,000 for 6 events over 12 months and $10,000 for promotion of events, to building education, empowerment and inspiration through educational evening events.
Grant for $30,000 for fees associated with presence of Meningitis Centre at national baby expos to reach parents and soon-to-be parents.
Funding for $15,000 for peer support program - regular webinar series (10 per year) targeting a range of self-management issues.
Grant of $31,862 to Hepatits Victoria for a Health literacy program + Grantof $15,000 to expand the Lung Foundation Living Well Webinar series in 2020.
Grant of $20,000 to Hepatitis Australia towards World Hepatitis Day activities.
GSK granted $20,000 to support updating the Asthma Australia Handbook.
